Development & Partnerships Committee
Doug Schantz, Executive Director in Clinical Operations at AstraZeneca, has spent his entire career in healthcare, first as a paramedic, as a clinical trials coordinator at a network of urgent care facilities and for the last 29 years, in pharmaceutical clinical research serving in a wide variety of roles. He is passionate about clinical trials as a treatment option, particularly for underserved people, as well as making it easier for healthcare providers to engage in clinical trials.
In his current role, Doug heads up the US Site Management and Monitoring group at AstraZeneca Pharmaceuticals, LP and is based in Wilmington Delaware. He is responsible for a group of clinical trial leads, research associates and support staff located throughout the US who deliver AstraZeneca clinical trials through more than 2200 investigator sites nationwide. Doug is a member of the Leadership Council for the Society for Clinical Research Sites, where he has been an active participant and speaker since 2015.